Yunxia Tao

2.8k total citations
59 papers, 2.2k citations indexed

About

Yunxia Tao is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Yunxia Tao has authored 59 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 19 papers in Molecular Biology and 16 papers in Pathology and Forensic Medicine. Recurrent topics in Yunxia Tao's work include Lymphoma Diagnosis and Treatment (10 papers), Lung Cancer Treatments and Mutations (9 papers) and Genetic and Kidney Cyst Diseases (8 papers). Yunxia Tao is often cited by papers focused on Lymphoma Diagnosis and Treatment (10 papers), Lung Cancer Treatments and Mutations (9 papers) and Genetic and Kidney Cyst Diseases (8 papers). Yunxia Tao collaborates with scholars based in China, United States and France. Yunxia Tao's co-authors include Charles L. Edelstein, Robert W. Schrier, Jun Kim, Sarah Faubel, Dechun Geng, Sandor Falk, Zonghan Dai, Zhibin He, Yaozeng Xu and Jonathan M. Horowitz and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Yunxia Tao

58 papers receiving 2.2k citations

Peers

Yunxia Tao
Petra Seemann Germany
Takahito Ito Japan
Rong Dong China
Keisuke Kawasaki Japan
Weihua Yuan China
Ruth McCracken United States
P. Ballanti Italy
Sawako Tatsumi Japan
Andrea Bábelová Germany
Andong Qiu United States
Petra Seemann Germany
Yunxia Tao
Citations per year, relative to Yunxia Tao Yunxia Tao (= 1×) peers Petra Seemann

Countries citing papers authored by Yunxia Tao

Since Specialization
Citations

This map shows the geographic impact of Yunxia Tao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yunxia Tao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yunxia Tao more than expected).

Fields of papers citing papers by Yunxia Tao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yunxia Tao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yunxia Tao. The network helps show where Yunxia Tao may publish in the future.

Co-authorship network of co-authors of Yunxia Tao

This figure shows the co-authorship network connecting the top 25 collaborators of Yunxia Tao. A scholar is included among the top collaborators of Yunxia Tao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yunxia Tao. Yunxia Tao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tao, Yunxia, et al.. (2024). Real‑world evaluation of the efficacy of immune checkpoint inhibitors in the treatment of metastatic breast cancer. Oncology Letters. 29(1). 29–29. 5 indexed citations
2.
Feng, Yu, Yunxia Tao, Haizhu Chen, et al.. (2023). Efficacy and safety of immune checkpoint inhibitor rechallenge in non‐small cell lung cancer: A systematic review and meta‐analysis. Thoracic Cancer. 14(25). 2536–2547. 15 indexed citations
3.
4.
5.
Tao, Yunxia, Yu Zhou, Le Tang, et al.. (2022). Toxicity profile of anaplastic lymphoma kinase tyrosine kinase inhibitors for patients with non-small cell lung cancer: A systematic review and meta-analysis. Investigational New Drugs. 40(4). 831–840. 11 indexed citations
6.
Zhong, Qiaofeng, Yunxia Tao, Haizhu Chen, et al.. (2021). The changing landscape of anti-lung cancer drug clinical trials in mainland China from 2005 to 2020. The Lancet Regional Health - Western Pacific. 11. 100151–100151. 19 indexed citations
7.
8.
Yu, Binqing, Jiaxiang Bai, Jian Qing Shi, et al.. (2020). MiR‐106b inhibition suppresses inflammatory bone destruction of wear debris‐induced periprosthetic osteolysis in rats. Journal of Cellular and Molecular Medicine. 24(13). 7490–7503. 12 indexed citations
9.
10.
Wu, Xiexing, Yu Liu, Xiaobin Guo, et al.. (2018). Prolactin inhibits the progression of intervertebral disc degeneration through inactivation of the NF-κB pathway in rats. Cell Death and Disease. 9(2). 98–98. 59 indexed citations
11.
Wang, Wenna, Yunxia Tao, Xiao Lyu, et al.. (2016). Phase II and UGT1A1 Polymorphism Study of Two Different Irinotecan Dosages Combined with Cisplatin as First-Line Therapy for Advanced Gastric Cancer. Chemotherapy. 61(4). 197–203. 5 indexed citations
12.
Hu, Xuanyang, Zichuan Ping, Minfeng Gan, et al.. (2016). Theaflavin-3,3′-digallate represses osteoclastogenesis and prevents wear debris-induced osteolysis via suppression of ERK pathway. Acta Biomaterialia. 48. 479–488. 58 indexed citations
13.
Tao, Yunxia, et al.. (2015). [A analysis of the outcome and prognostic factors in 415 patients with Hodgkin lymphoma].. PubMed. 37(6). 466–71. 1 indexed citations
14.
Liu, Bin, et al.. (2012). Increasing extracellular matrix collagen level and MMP activity induces cyst development in polycystic kidney disease. BMC Nephrology. 13(1). 109–109. 29 indexed citations
15.
Tang, Hongxing, et al.. (2011). CDK1-mediated Phosphorylation of Abi1 Attenuates Bcr-Abl-induced F-actin Assembly and Tyrosine Phosphorylation of WAVE Complex during Mitosis. Journal of Biological Chemistry. 286(44). 38614–38626. 13 indexed citations
16.
Li, Chenghai, Bin Liu, Zonghan Dai, & Yunxia Tao. (2011). Knockdown of VEGF receptor-1 (VEGFR-1) impairs macrophage infiltration, angiogenesis and growth of clear cell renal cell carcinoma (CRCC). Cancer Biology & Therapy. 12(10). 872–880. 51 indexed citations
17.
Tao, Yunxia, Yajie Yin, Iram Zafar, et al.. (2007). VEGF receptor inhibition slows the progression of polycystic kidney disease. Kidney International. 72(11). 1358–1366. 50 indexed citations
18.
Douglas, Ivor S., Christina L. Klein, Zhibin He, et al.. (2006). Acute Renal Failure after Bilateral Nephrectomy Is Associated with Cytokine-Mediated Pulmonary Injury. Journal of the American Society of Nephrology. 18(1). 155–164. 240 indexed citations
19.
Tao, Yunxia, et al.. (1997). Subunit Composition Determines E2F DNA-Binding Site Specificity. Molecular and Cellular Biology. 17(12). 6994–7007. 116 indexed citations
20.
Tao, Yunxia, et al.. (1993). Purification, characterization and immunoassay of striped bass (Morone saxatilis) vitellogenin. Fish Physiology and Biochemistry. 12(1). 31–46. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Petra Seemann Breakdown of academic impact, for papers by Takahito Ito Breakdown of academic impact, for papers by Rong Dong Breakdown of academic impact, for papers by Keisuke Kawasaki Breakdown of academic impact, for papers by Weihua Yuan Breakdown of academic impact, for papers by Ruth McCracken Breakdown of academic impact, for papers by P. Ballanti Breakdown of academic impact, for papers by Sawako Tatsumi Breakdown of academic impact, for papers by Andrea Bábelová Breakdown of academic impact, for papers by Andong Qiu
Rankless by CCL
2026